Exane Derivatives’s Canadian National Railway CNI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-134
Closed -$14.2K 838
2020
Q3
$14.2K Hold
134
﹤0.01% 456
2020
Q2
$11.8K Hold
134
﹤0.01% 411
2020
Q1
$10.3K Hold
134
﹤0.01% 427
2019
Q4
$12.7K Hold
134
﹤0.01% 408
2019
Q3
$12K Sell
134
-411
-75% -$38K ﹤0.01% 421
2019
Q2
$50.5K Hold
545
0.01% 390
2019
Q1
$48.8K Hold
545
0.01% 340
2018
Q4
$40.4K Hold
545
0.01% 375
2018
Q3
$48.9K Hold
545
0.01% 371
2018
Q2
$44.1K Hold
545
0.01% 395
2018
Q1
$39K Hold
545
0.01% 366
2017
Q4
$45K Hold
545
0.01% 349
2017
Q3
$45.3K Hold
545
0.01% 314
2017
Q2
$44.2K Hold
545
0.01% 323
2017
Q1
$40.3K Hold
545
0.01% 278
2016
Q4
$36.6K Hold
545
0.01% 317
2016
Q3
$35.5K Hold
545
0.01% 328
2016
Q2
$32.1K Hold
545
0.01% 304
2016
Q1
$34.2K Hold
545
﹤0.01% 348
2015
Q4
$30.4K Hold
545
﹤0.01% 276
2015
Q3
$30.2K Hold
545
﹤0.01% 301
2015
Q2
$31.7K Sell
545
-486
-47% -$30.4K ﹤0.01% 317
2015
Q1
$67.5K Sell
1,031
-2,170
-68% -$148K 0.01% 292
2014
Q4
$221K Buy
+3,201
New +$219K 0.03% 201

Other funds holding CNI

Exane Derivatives's CNI Position: Q4 2020 in Review

Exane Derivatives sold out of Canadian National Railway (CNI) in Q4 2020, closing a stake of 134 shares — an estimated $14.2K sold.

Exane Derivatives first reported a position in CNI in Q4 2014 and held it in 24 quarters. The position peaked at $221K in Q4 2014. 701 funds tracked by Wall St. Rank hold CNI as of Q4 2020.

  • Exane Derivatives reported no remaining Canadian National Railway position as of Q4 2020 after selling out during the quarter.
  • Exane Derivatives sold 134 Canadian National Railway shares in Q4 2020, an estimated $14.2K.
  • Exane Derivatives first reported a position in Canadian National Railway in Q4 2014 and held it in 24 quarters.
  • Exane Derivatives's Canadian National Railway position peaked at $221K in Q4 2014.
  • 701 funds tracked by Wall St. Rank held Canadian National Railway as of Q4 2020.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.